These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapy-related, donor-derived AML responding to a second allogeneic BMT. Jacobs JF; Brons PP; Simons A; van der Reijden BA; Hoogerbrugge PM Bone Marrow Transplant; 2007 Sep; 40(5):499-500. PubMed ID: 17589531 [No Abstract] [Full Text] [Related]
4. A case of therapy-related acute myeloid leukemia associated with inv(16), with subsequent development of t(9;22). Kim M; Lim J; Kim Y; Han K; Kang CS; Kim HJ; Min WS Leukemia; 2006 Apr; 20(4):746-8. PubMed ID: 16437154 [No Abstract] [Full Text] [Related]
5. [Coexistence of implantation and autologous blastic crisis after bone marrow transplant in chronic myeloid leukemia]. Ribera JM; Feliu E; Vives-Corrons JL; Marín P; Grañena A; Rozman C Sangre (Barc); 1986; 31(2):205-12. PubMed ID: 3523798 [No Abstract] [Full Text] [Related]
6. Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia. Tomonari A; Tojo A; Adachi D; Iseki T; Ooi J; Shirafuji N; Tani K; Asano S Ann Hematol; 2003 Jan; 82(1):37-40. PubMed ID: 12574963 [TBL] [Abstract][Full Text] [Related]
7. Current progress in the treatment of adult acute leukemia in Japan. Ohno R Jpn J Clin Oncol; 1993 Apr; 23(2):85-97. PubMed ID: 7685836 [No Abstract] [Full Text] [Related]
8. Severe esophageal stricture after autologous bone marrow transplant. Stemmelin GR; Pest P; Peters RA; Ceresetto JM; Shanley CM; Bullorsky EO Bone Marrow Transplant; 1995 Jun; 15(6):1001-2. PubMed ID: 7581074 [No Abstract] [Full Text] [Related]
9. Pulmonary toxoplasmosis after allogeneic bone marrow transplantation: case report and review. Saad R; Vincent JF; Cimon B; de Gentile L; Francois S; Bouachour G; Ifrah N Bone Marrow Transplant; 1996 Jul; 18(1):211-2. PubMed ID: 8832018 [TBL] [Abstract][Full Text] [Related]
10. Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. Schlenk RF; Benner A; Krauter J; Büchner T; Sauerland C; Ehninger G; Schaich M; Mohr B; Niederwieser D; Krahl R; Pasold R; Döhner K; Ganser A; Döhner H; Heil G J Clin Oncol; 2004 Sep; 22(18):3741-50. PubMed ID: 15289486 [TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Gopcsa L; Barta A; Banyai A; Konya M; Pajor L; Földi J; Paloczi K Bone Marrow Transplant; 2002 Mar; 29(5):449-52. PubMed ID: 11919736 [TBL] [Abstract][Full Text] [Related]
12. High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation. Lee KH; Lee JH; Kim S; Lee JS; Kim SH; Kim WK Bone Marrow Transplant; 2000 Jul; 26(2):147-52. PubMed ID: 10918424 [TBL] [Abstract][Full Text] [Related]
13. Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies. Malladi RK; Peniket AJ; Norton AE; Campbell AJ; Collins GP; Samol J; Eagleton H; Miller E; Morgenstern G; Jones J; Keen-Mcguire A; Barnardo M; Littlewood TJ Eur J Haematol; 2004 Aug; 73(2):85-92. PubMed ID: 15245506 [TBL] [Abstract][Full Text] [Related]
14. Myeloid/natural killer cell precursor acute leukemia with tetraploidy. Dinçol G; Palandüz S; Nalçaci M; Uçur A; Büyükaydin B Cancer Genet Cytogenet; 2005 Dec; 163(2):156-9. PubMed ID: 16337859 [TBL] [Abstract][Full Text] [Related]
15. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups. Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of leukemic contamination in peripheral blood stem cell leukaphereses vs bone marrow after consolidation therapy in acute myeloid leukemia: not a critical factor in outcome? Melillo L; Specchia G; Ferrara F; Minervini MM; Pastore D; Carella AM Haematologica; 2003 Jun; 88(6):715-8. PubMed ID: 12801851 [No Abstract] [Full Text] [Related]
17. Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias. Burke JM; Caron PC; Papadopoulos EB; Divgi CR; Sgouros G; Panageas KS; Finn RD; Larson SM; O'Reilly RJ; Scheinberg DA; Jurcic JG Bone Marrow Transplant; 2003 Sep; 32(6):549-56. PubMed ID: 12953125 [TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus pneumonitis, activated prothrombin time prolongation and subacute thyroiditis after unrelated allogeneic bone marrow transplantation. Kawano C; Muroi K; Akioka T; Izumi T; Kodera Y; Ozawa K Bone Marrow Transplant; 2000 Dec; 26(12):1347-9. PubMed ID: 11223977 [TBL] [Abstract][Full Text] [Related]
19. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268 [TBL] [Abstract][Full Text] [Related]
20. Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma. Matsunaga T; Murase K; Yoshida M; Fujimi A; Iyama S; Kuribayashi K; Sato T; Kogawa K; Hirayama Y; Sakamaki S; Kohda K; Niitsu Y Am J Hematol; 2005 Aug; 79(4):294-8. PubMed ID: 16044441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]